In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...
However experts say many of those deaths could be prevented. Colorectal cancer is one of the cancers for which effective screening exists. For one thing, colorectal cancer nearly always develops from ...
The Shield blood test developed by Guardant has been approved by the FDA as a primary screening option for colorectal cancer, providing a more convenient method of screening. Guardant’s Shield blood ...
The U.S. Food and Drug Administration on Monday approved a new blood test that can spot colon cancer. In late May, an FDA advisory panel had voted 7–2 that the benefits outweigh the risks when using ...
Time for a rear-ality check. Colorectal cancer rates have been rising among adults younger than 50 since the 1990s, a troubling trend that has perplexed scientists. Because of the increase in cases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results